14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PASG
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaluation of Passage Bio, Inc. stock downgraded after the last trading session.
(Updated on May 17, 2024)

Sell candidate since May 17, 2024 PDF

The Passage Bio, Inc. stock price fell by -1.49% on the last day (Friday, 17th May 2024) from $1.34 to $1.32. During the last trading day the stock fluctuated 5.30% from a day low at $1.32 to a day high of $1.39. The price has been going up and down for this period, and there has been a 0.76% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -79 thousand shares and in total, 38 thousand shares were bought and sold for approximately $50.79 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -10.37% during the next 3 months and, with a 90% probability hold a price between $0.97 and $1.40 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PASG Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Passage Bio, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $1.38 and $1.33. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, May 07, 2024, and so far it has fallen -16.46%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Passage Bio, Inc. stock

Passage Bio, Inc. finds support from accumulated volume at $1.30 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0700 between high and low, or 5.30%. For the last week the stock has had daily average volatility of 13.09%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PASG) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Passage Bio, Inc. to open at $1.34, and during the day (based on 14 day Average True Range), to move between $1.19 and $1.45, which gives a possible trading interval of +/-$0.134 (+/-10.12%) up or down from last closing price. If Passage Bio, Inc. takes out the full calculated possible swing range there will be an estimated 20.24% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.30 (1.52%) than the resistance at $1.35 (2.27%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Passage Bio, Inc. stock A Buy?

Passage Bio, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -1.725 Sell Candidate Downgraded

Predicted Opening Price for Passage Bio, Inc. of Monday, May 20, 2024

Fair opening price May 20, 2024 Current price
$1.34 ( 1.77%) $1.32

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PASG

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.41 7.07 %
R2 1.39 5.04 %
R1 1.37 3.79 %
Current price: 1.32
Support S1 1.32 -0.258 %
S2 1.30 -1.51 %
S3 1.27 -3.54 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.46 10.61 %
R2 1.40 6.06 %
R1 1.35 2.27 %
Current price 1.32
Support S1 1.30 -1.52%
S2 1.27 -3.79%
S3 1.24 -6.06%

FAQ

What is the symbol for Passage Bio, Inc. Stock and on which exchange is it traded?
The symbol for Passage Bio, Inc. is PASG and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Passage Bio, Inc. Stock?
Passage Bio, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Passage Bio, Inc. Stock?
Passage Bio, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Passage Bio, Inc. Stock.

What's the current price of Passage Bio, Inc. Stock?
As of the end of day on the May 17, 2024, the price of an Passage Bio, Inc. (PASG) share was $1.32.

What is the 52-week high and low for Passage Bio, Inc. Stock?
The 52-week high for Passage Bio, Inc. Stock is $1.79 and the 52-week low is $0.575.

What is the market capitalization of Passage Bio, Inc. Stock?
As of the May 17, 2024, the market capitalization of Passage Bio, Inc. is 82.598M.

When is the next earnings date for Passage Bio, Inc.?
The upcoming earnings date for Passage Bio, Inc. is Aug 05, 2024.
Click to get the best stock tips daily for free!

About Passage Bio, Inc.

Passage Bio. Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 capsid to deliver to the brain a functional granulin (GRN) and gene encoding progranulin (PGRN) for the... PASG Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT